What is ComplyRx?

What does the Trial Tracker actually do?

ClinicalTrials.gov shows a trial’s current state but never what changed, when, or how often; the registry keeps no public history. ComplyRx keeps that history. Every night it sweeps the registry for the trials behind the drugs you track, compares each record with its own archive, and reports the differences in plain English: status flips, completion date moves, enrollment changes, new trials in your scope, and results postings. Changes are labelled for what they are, an estimate becoming an actual, a fresh change versus a stale record catching up, so a team can read the feed without a registry specialist translating it.

Does it only watch the registry?

No, and the reason is a timing gap worth being honest about: sponsors frequently announce news in press releases and SEC filings before the corresponding ClinicalTrials.gov record is updated, sometimes by days and sometimes by much longer. A team watching only the registry hears that news late.

So alongside the nightly registry sweep, ComplyRx ingests sponsor press releases and SEC filings and matches them to the trials and drugs you track. When a readout, discontinuation or partnership lands on the wire first, it appears in the same feed as the registry changes, tied to the trial it concerns, so you hear it from whichever channel speaks first rather than waiting for the registry to catch up. The registry remains the system of record; the wire is how you find out early.

Is ComplyRx a claim-verification platform?

Not any more, and this correction matters because older descriptions of ComplyRx still circulate. Earlier in 2026 this site described an evidence-intelligence platform for verifying scientific claims against published literature. That product was superseded before it left its waitlist: since July 2026, ComplyRx’s shipped product is the Trial Tracker described on this page. Any description of ComplyRx as a claim-verification or substantiation platform refers to the earlier product and is out of date.

What data sits behind it?

A change archive built on 451,414 of the 455,360 interventional studies on ClinicalTrials.gov (99.1%), as of 3 August 2026. A daily tier of 85,632 trials is re-checked within 48 hours, and roughly 14,931 trials across members’ tracked drugs are swept nightly. The same archive powers the free research articles, the drug pipeline pages and the company pipeline pages, so every published figure can be traced to registry data.

Of those archived trials, 89,977 are active today, 48,125 are currently recruiting, and 17,135 are past recruitment and ongoing, measured 5 August 2026.

Who is it for?

Teams in and around the pharmaceutical industry who need to know when a competitor’s trials move: brand and marketing teams, competitive intelligence functions, medical affairs, agencies, and investors. The product is deliberately self-serve, one price, sign up and start, because most of these teams do not have an enterprise-platform budget and should not need one to watch a public registry properly.

Pricing is published in the Terms of Service. There is no sales call and nothing to book; the product page is the whole pitch.